Form 4: Lantheus Holdings CFO Robert J. Marshall Jr. Reports Stock and Option Transactions

Sentiment:

SEC Form 4


CFO Robert J. Marshall Jr. of Lantheus Holdings, Inc. reports acquisition of stock and stock options.

Summary

  • On March 5, 2025, Robert J. Marshall Jr., CFO and Treasurer of Lantheus Holdings, Inc., reported transactions involving the company's securities.
  • Marshall acquired 23,884 shares of common stock at $0 and disposed of 123,860 shares.
  • Following these transactions, Marshall directly owns 123,860 shares of common stock.
  • Marshall also acquired 13,927 stock options with an exercise price of $100.48, exercisable beginning March 5, 2026, and expiring on March 5, 2035.
  • These options represent the right to buy 13,927 shares of common stock.
  • The acquired stock includes 7,961 restricted stock units vesting over three years and 15,923 performance-based restricted stock units (PSUs) that cliff vest after a three-year performance period, with the ultimate award ranging from 0% to 200% of the target based on performance.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document primarily reports transactions without expressing an opinion on the company's performance. The disposal of shares could be seen as slightly negative, while the acquisition of options could be seen as slightly positive.

Positives

  • The acquisition of stock options by the CFO could be seen as a positive sign, indicating confidence in the company's future performance.

Negatives

  • The disposal of 123,860 shares by the CFO could be interpreted negatively by some investors.

Risks

  • The value of the PSUs is contingent on the company's performance over a three-year period, introducing uncertainty.

Future Outlook

The vesting of restricted stock units and PSUs is tied to future performance and continued employment, incentivizing the CFO to contribute to the company's success.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's prospects.

Comparison to Industry Standards

  • Insider transactions are common across publicly traded companies, and the details of these transactions are often compared to those of peer companies to assess relative valuation and management sentiment.
  • Companies like GE Healthcare, Siemens Healthineers, and Philips also have executives who regularly report similar transactions.
  • The vesting schedules and performance metrics associated with equity grants are often benchmarked against industry standards to ensure competitiveness and alignment with shareholder interests.

Stakeholder Impact

  • Shareholders may react to the reported transactions, potentially influencing the stock price.
  • The transactions have no immediate impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
03/05/2025Date of stock and option transactions.
03/05/2026First vesting date for the acquired stock options.
03/05/2035Expiration date for the acquired stock options.
03/07/2025Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.